Charbel Massaad et la lutte contre la fraude
Charbel Massaad is head of biomedical sciences at University of Paris Descartes. He even put forward his candidacy as rector, advocating for science ethics. Unironically.
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Charbel Massaad is head of biomedical sciences at University of Paris Descartes. He even put forward his candidacy as rector, advocating for science ethics. Unironically.
David Sabatini is an absolute star scientist, and now he is being harassed. On PubPeer and Twitter. It is all very unfair.
Euroimmun founder Winfried Stöcker replies to criticism of his company’s publications: “Dr. Elisabeth Bik’s observations are not suitable to bring us into disrepute.”
A breast cancer foundation celebrates its research heroes. Read now here about how great US scientists from Harvard, MIT, Weill Cornell and MD Anderson cure cancer.
Smut Clyde studies two Chinese research groups to understand how TCM can be used to create modern Photoshop art.
“now we have equipped with our own photo microscopy, we didn’t depend on the out sourcing fellows to take the photography our slides”. – Dr Milton Prabu.
As one Nobelist retracted her Science paper, another Nobelist has stealthily corrected his. The correction opens new dimensions of probabilities and is indeed best kept hidden.
EuroImmun is a German diagnostics biotech, founded by the most charming Professor Stöcker and recently sold to PerkinElmer. Elisabeth Bik checked some of company’s papers, many coauthored by Stöcker himself, and she raised questions. The company says this “testifies to a lack of knowledge of the matter”.
Smut Clyde is back with more fraudulent nanotechnology. This time, he presents the works of Dhanaraj Gopi, who designs fabricated surfaces for surgical implants. In Photoshop, or with a pencil.
The prion researcher Adriano Aguzzi used to describe his Pubpeer critics as “lowlifes”, and himself as a victim of a lynch mob. But after Elisabeth Bik helped him find even more mistakes in his papers, Aguzzi changed his stance.









